SCHEDULE 13G Filed 2026-08-28 Event — SEC 0000929638-26-003281 →

Lind Global Fund III LP → Dare Bioscience, Inc. DARE

Stake: — Shares: — Class: Common Stock, $0.0001 par value

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

12 13D/G filings on this issuer

11 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-08-14

DTC 1.00

1,166,572 shares short · +38.9% vs prior

Other 13D/G Filings on Dare Bioscience, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-24	SCHEDULE 13G	L1 Capital Global Opportunities Master Fund, Ltd.	—	—	view →
2020-04-01	SC	HAWLEY ROGER	—	—	view →
2020-02-21	SC	Dare Bioscience, Inc.	—	—	view →
2019-12-09	SC	Dare Bioscience, Inc.	—	—	view →
2019-04-16	SC	Walters Mark	—	—	view →
2019-04-15	SC	HAWLEY ROGER	—	—	view →
2019-04-15	SC	Walters-Hoffert Lisa	—	—	view →
2019-04-15	SC	JOHNSON SABRINA MARTUCCI	—	—	view →
2019-02-14	SC	POLARIS VENTURE PARTNERS IV LP	—	—	view →
2019-02-14	SC	Polaris Venture Partners V, L.P.	—	—	view →
2019-02-14	SC	Crane Alan L	—	—	view →

Other Filings by Lind Global Fund III LP

Filed	Form	Issuer	Stake	Shares
2026-08-25	SCHEDULE 13G	DEFSEC Technologies Inc.	—	—	view →
2026-08-05	SCHEDULE 13G	60 DEGREES PHARMACEUTICALS, INC.	—	—	view →
2026-07-15	SCHEDULE 13G	DEFSEC Technologies Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →